{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:46:11Z","timestamp":1790610371709,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s12035-018-1163-0","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T06:33:53Z","timestamp":1528353233000},"page":"1221-1232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["(E)-Nicotinaldehyde O-Cinnamyloxime, a Nicotine Analog, Attenuates Neuronal Cells Death Against Rotenone-Induced Neurotoxicity"],"prefix":"10.1007","volume":"56","author":[{"given":"Juan Camilo","family":"Jurado-Coronel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alix E.","family":"Loaiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghulam Md","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Echeverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneth","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6644-1971","authenticated-orcid":false,"given":"George E.","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"issue":"2","key":"1163_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tox.2009.06.004","volume":"262","author":"HJ Kim","year":"2009","unstructured":"Kim HJ, Park HJ, Park HK, Chung JH (2009) Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Toxicology 262(2):171\u2013174","journal-title":"Toxicology"},{"key":"1163_CR2","first-page":"340","volume":"6","author":"GE Barreto","year":"2014","unstructured":"Barreto GE, Iarkov A, Moran VE (2014) Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease. Front Aging Neurosci 6:340","journal-title":"Front Aging Neurosci"},{"issue":"25","key":"1163_CR3","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.2174\/1381612821666150710145250","volume":"21","author":"GE Barreto","year":"2015","unstructured":"Barreto GE, Yarkov A, Avila-Rodriguez M, Aliev G, Echeverria V (2015) Nicotine-derived compounds as therapeutic tools against post-traumatic stress disorder. Curr Pharm Des 21(25):3589\u20133595","journal-title":"Curr Pharm Des"},{"issue":"10","key":"1163_CR4","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2174\/138161282210160304112511","volume":"22","author":"V Echeverria","year":"2016","unstructured":"Echeverria V, Grizzell JA, Barreto GE (2016a) Neuroinflammation: A therapeutic target of cotinine for the treatment of psychiatric disorders? Curr Pharm Des 22(10):1324\u20131333","journal-title":"Curr Pharm Des"},{"key":"1163_CR5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pneurobio.2016.01.002","volume":"144","author":"V Echeverria","year":"2016","unstructured":"Echeverria V, Yarkov A, Aliev G (2016b) Positive modulators of the alpha7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer's disease. Prog Neurobiol 144:142\u2013157","journal-title":"Prog Neurobiol"},{"key":"1163_CR6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pnpbp.2017.05.010","volume":"78","author":"JA Grizzell","year":"2017","unstructured":"Grizzell JA, Patel S, Barreto GE, Echeverria V (2017) Cotinine improves visual recognition memory and decreases cortical tau phosphorylation in the Tg6799 mice. Prog Neuro-Psychopharmacol Biol Psychiatry 78:75\u201381","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"10","key":"1163_CR7","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2174\/138161282210160304112133","volume":"22","author":"JC Jurado-Coronel","year":"2016","unstructured":"Jurado-Coronel JC, Avila-Rodriguez M, Capani F, Gonzalez J, Moran VE, Barreto GE (2016) Targeting the nicotinic acetylcholine receptors (nAChRs) in astrocytes as a potential therapeutic target in Parkinson's disease. Curr Pharm Des 22(10):1305\u20131311","journal-title":"Curr Pharm Des"},{"key":"1163_CR8","doi-asserted-by":"crossref","unstructured":"Mendoza C, Barreto GE, Iarkov A, Tarasov VV, Aliev G, Echeverria V (2018) Cotinine: A therapy for memory extinction in post-traumatic stress disorder. Mol Neurobiol","DOI":"10.1007\/s12035-018-0869-3"},{"key":"1163_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.expneurol.2017.06.016","volume":"295","author":"N Perez-Urrutia","year":"2017","unstructured":"Perez-Urrutia N, Mendoza C, Alvarez-Ricartes N, Oliveros-Matus P, Echeverria F, Grizzell JA, Barreto GE, Iarkov A et al (2017) Intranasal cotinine improves memory, and reduces depressive-like behavior, and GFAP+ cells loss induced by restraint stress in mice. Exp Neurol 295:211\u2013221","journal-title":"Exp Neurol"},{"issue":"7","key":"1163_CR10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/aps.2009.70","volume":"30","author":"SQ Ye","year":"2009","unstructured":"Ye SQ, Zhou XY, Lai XJ, Zheng L, Chen XQ (2009) Silencing neuroglobin enhances neuronal vulnerability to oxidative injury by down-regulating 14-3-3gamma. Acta Pharmacol Sin 30(7):913\u2013918","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"1163_CR11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bcp.2009.05.003","volume":"78","author":"M Quik","year":"2009","unstructured":"Quik M, Huang LZ, Parameswaran N, Bordia T, Campos C, Perez XA (2009) Multiple roles for nicotine in Parkinson's disease. Biochem Pharmacol 78(7):677\u2013685","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1163_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pneurobio.2008.03.003","volume":"85","author":"RJ Ward","year":"2008","unstructured":"Ward RJ, Lallemand F, de Witte P, Dexter DT (2008) Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: Potential targets for the development of new therapeutic agents. Prog Neurobiol 85(2):135\u2013147","journal-title":"Prog Neurobiol"},{"key":"1163_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","volume":"49","author":"NL Benowitz","year":"2009","unstructured":"Benowitz NL (2009) Pharmacology of nicotine: Addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49:57\u201371","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"16","key":"1163_CR14","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1021\/acs.jmedchem.5b00904","volume":"58","author":"C Bolchi","year":"2015","unstructured":"Bolchi C, Valoti E, Gotti C, Fasoli F, Ruggeri P, Fumagalli L, Binda M, Mucchietto V et al (2015) Chemistry and pharmacology of a series of Unichiral analogues of 2-(2-Pyrrolidinyl)-1,4-benzodioxane, Prolinol phenyl ether, and Prolinol 3-Pyridyl ether designed as alpha4beta2-nicotinic acetylcholine receptor agonists. J Med Chem 58(16):6665\u20136677","journal-title":"J Med Chem"},{"issue":"13","key":"1163_CR15","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.bmcl.2016.04.031","volume":"26","author":"CB Deng","year":"2016","unstructured":"Deng CB, Li J, Li LY, Sun FJ (2016) Protective effect of novel substituted nicotine hydrazide analogues against hypoxic brain injury in neonatal rats via inhibition of caspase. Bioorg Med Chem Lett 26(13):3195\u20133201","journal-title":"Bioorg Med Chem Lett"},{"issue":"1\u20133","key":"1163_CR16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2007.02.038","volume":"563","author":"D Pogocki","year":"2007","unstructured":"Pogocki D, Ruman T, Danilczuk M, Danilczuk M, Celuch M, Walajtys-Rode E (2007) Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders. Eur J Pharmacol 563(1\u20133):18\u201339","journal-title":"Eur J Pharmacol"},{"issue":"1\u20132","key":"1163_CR17","first-page":"42","volume":"1003","author":"TS Rao","year":"2004","unstructured":"Rao TS, Sacaan AI, Menzaghi FM, Reid RT, Adams PB, Correa LD, Whelan KT, Vernier JM (2004) Pharmacological characterization of SIB-1663, a conformationally rigid analog of nicotine. Brain Res 1003(1\u20132):42\u201353","journal-title":"Brain Res"},{"issue":"12","key":"1163_CR18","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/cjoc.201200952","volume":"30","author":"J Wang","year":"2012","unstructured":"Wang J, Li X, Yuan Q, Ren J, Huang J, Zeng B (2012) Synthesis and pharmacological properties of 5-alkyl substituted nicotine analogs. Chin J Chem 30(12):2813\u20132818","journal-title":"Chin J Chem"},{"issue":"1","key":"1163_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/1476830511Y.0000000028","volume":"15","author":"SL Albarracin","year":"2012","unstructured":"Albarracin SL, Stab B, Casas Z, Sutachan JJ, Samudio I, Gonzalez J, Gonzalo L, Capani F et al (2012) Effects of natural antioxidants in neurodegenerative disease. Nutr Neurosci 15(1):1\u20139","journal-title":"Nutr Neurosci"},{"issue":"28","key":"1163_CR20","first-page":"4180","volume":"23","author":"NA Mazo","year":"2017","unstructured":"Mazo NA, Echeverria V, Cabezas R, Avila-Rodriguez M, Tarasov VV, Yarla NS, Aliev G, Barreto GE (2017) Medicinal plants as protective strategies against Parkinson's disease. Curr Pharm Des 23(28):4180\u20134188","journal-title":"Curr Pharm Des"},{"issue":"3","key":"1163_CR21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1179\/1476830511Y.0000000033","volume":"15","author":"JJ Sutachan","year":"2012","unstructured":"Sutachan JJ, Casas Z, Albarracin SL, Stab BR 2nd, Samudio I, Gonzalez J, Morales L, Barreto GE (2012) Cellular and molecular mechanisms of antioxidants in Parkinson's disease. Nutr Neurosci 15(3):120\u2013126","journal-title":"Nutr Neurosci"},{"issue":"6","key":"1163_CR22","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.bbadis.2012.02.004","volume":"1822","author":"L Guo","year":"2012","unstructured":"Guo L, Li L, Wang W, Pan Z, Zhou Q, Wu Z (2012) Mitochondrial reactive oxygen species mediates nicotine-induced hypoxia-inducible factor-1alpha expression in human non-small cell lung cancer cells. Biochim Biophys Acta 1822(6):852\u2013861","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"1163_CR23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00002512-200118110-00001","volume":"18","author":"GW Ross","year":"2001","unstructured":"Ross GW, Petrovitch H (2001) Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease. Drugs Aging 18(11):797\u2013806","journal-title":"Drugs Aging"},{"issue":"4","key":"1163_CR24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12640-014-9509-5","volume":"27","author":"R Cabezas","year":"2015","unstructured":"Cabezas R, Avila MF, Gonzalez J, El-Bacha RS, Barreto GE (2015) PDGF-BB protects mitochondria from rotenone in T98G cells. Neurotox Res 27(4):355\u2013367","journal-title":"Neurotox Res"},{"issue":"2","key":"1163_CR25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neures.2012.07.008","volume":"74","author":"R Cabezas","year":"2012","unstructured":"Cabezas R, El-Bacha RS, Gonzalez J, Barreto GE (2012) Mitochondrial functions in astrocytes: Neuroprotective implications from oxidative damage by rotenone. Neurosci Res 74(2):80\u201390","journal-title":"Neurosci Res"},{"issue":"4","key":"1163_CR26","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1007\/s12035-017-0567-6","volume":"55","author":"R Cabezas","year":"2018","unstructured":"Cabezas R, Vega-Vela NE, Gonzalez-Sanmiguel J, Gonzalez J, Esquinas P, Echeverria V, Barreto GE (2018) PDGF-BB preserves mitochondrial morphology, attenuates ROS production, and upregulates Neuroglobin in an astrocytic model under rotenone insult. Mol Neurobiol 55(4):3085\u20133095","journal-title":"Mol Neurobiol"},{"key":"1163_CR27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brainres.2007.07.083","volume":"1176","author":"WG Chung","year":"2007","unstructured":"Chung WG, Miranda CL, Maier CS (2007) Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells. Brain Res 1176:133\u2013142","journal-title":"Brain Res"},{"issue":"9","key":"1163_CR28","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1177\/0960327110389837","volume":"30","author":"DM Oliveira de","year":"2011","unstructured":"de Oliveira DM, Barreto G, Galeano P, Romero JI, Holubiec MI, Badorrey MS, Capani F, Alvarez LD (2011) Paullinia cupana Mart. Var. Sorbilis protects human dopaminergic neuroblastoma SH-SY5Y cell line against rotenone-induced cytotoxicity. Hum Exp Toxicol 30(9):1382\u20131391","journal-title":"Hum Exp Toxicol"},{"issue":"2","key":"1163_CR29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11064-008-9749-y","volume":"34","author":"DM Oliveria de","year":"2009","unstructured":"de Oliveria DM, Barreto G, De Andrade DV, Saraceno E, Aon-Bertolino L, Capani F, Dos Santos El Bacha R, Giraldez LD (2009) Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease. Neurochem Res 34(2):215\u2013220","journal-title":"Neurochem Res"},{"key":"1163_CR30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2008.01.006","volume":"1198","author":"GDAD Valverde","year":"2008","unstructured":"Valverde GDAD, Madureira de Oliveria D, Barreto G, Bertolino LA, Saraceno E, Capani F, Giraldez LD (2008) Effects of the extract of Anemopaegma mirandum (Catuaba) on rotenone-induced apoptosis in human neuroblastomas SH-SY5Y cells. Brain Res 1198:188\u2013196","journal-title":"Brain Res"},{"issue":"10","key":"1163_CR31","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nn.2908","volume":"14","author":"SX Li","year":"2011","unstructured":"Li SX, Huang S, Bren N, Noridomi K, Dellisanti CD, Sine SM, Chen L (2011) Ligand-binding domain of an alpha7-nicotinic receptor chimera and its complex with agonist. Nat Neurosci 14(10):1253\u20131259","journal-title":"Nat Neurosci"},{"issue":"23","key":"1163_CR32","doi-asserted-by":"crossref","first-page":"7936","DOI":"10.1016\/j.bmc.2006.07.049","volume":"14","author":"H Yuan","year":"2006","unstructured":"Yuan H, Petukhov PA (2006) Computational evidence for the ligand selectivity to the alpha4beta2 and alpha3beta4 nicotinic acetylcholine receptors. Bioorg Med Chem 14(23):7936\u20137942","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"1163_CR33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"14","key":"1163_CR34","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"GM Morris","year":"1998","unstructured":"Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19(14):1639\u20131662","journal-title":"J Comput Chem"},{"issue":"3","key":"1163_CR35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.11144\/javeriana.SC16-3.saiv","volume":"16","author":"J Diaz-Velandia","year":"2011","unstructured":"Diaz-Velandia J, Dur\u00e1n-D\u00edaz N, Robles-Camargo J, Loaiza A (2011) Synthesis and in vitro assessment of antifungal activity of oximes, oxime ethers and isoxazoles. Univ Sci 16(3):294\u2013302","journal-title":"Univ Sci"},{"issue":"14","key":"1163_CR36","doi-asserted-by":"crossref","first-page":"10577","DOI":"10.1074\/jbc.R100005200","volume":"276","author":"AP Minton","year":"2001","unstructured":"Minton AP (2001) The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media. J Biol Chem 276(14):10577\u201310580","journal-title":"J Biol Chem"},{"key":"1163_CR37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.biophys.37.032807.125817","volume":"37","author":"HX Zhou","year":"2008","unstructured":"Zhou HX, Rivas G, Minton AP (2008) Macromolecular crowding and confinement: Biochemical, biophysical, and potential physiological consequences. Annu Rev Biophys 37:375\u2013397","journal-title":"Annu Rev Biophys"},{"issue":"5","key":"1163_CR38","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0028-3908(03)00041-8","volume":"44","author":"A Cormier","year":"2003","unstructured":"Cormier A, Morin C, Zini R, Tillement JP, Lagrue G (2003) Nicotine protects rat brain mitochondria against experimental injuries. Neuropharmacology 44(5):642\u2013652","journal-title":"Neuropharmacology"},{"issue":"10","key":"1163_CR39","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1111\/j.1530-0277.2000.tb04578.x","volume":"24","author":"MA Prendergast","year":"2000","unstructured":"Prendergast MA, Harris BR, Mayer S, Littleton JM (2000) Chronic, but not acute, nicotine exposure attenuates ethanol withdrawal-induced hippocampal damage in vitro. Alcohol Clin Exp Res 24(10):1583\u20131592","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"1163_CR40","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acschemneuro.6b00460","volume":"8","author":"SM Noha","year":"2017","unstructured":"Noha SM, Schmidhammer H, Spetea M (2017) Molecular docking, molecular dynamics, and structure-activity relationship explorations of 14-oxygenated N-Methylmorphinan-6-ones as potent mu-opioid receptor agonists. ACS Chem Neurosci 8(6):1327\u20131337","journal-title":"ACS Chem Neurosci"},{"key":"1163_CR41","first-page":"202","volume":"10","author":"A Shrivastava","year":"2017","unstructured":"Shrivastava A, Kumar K, Prasad K (2017) Molecular docking studies: The success should overrule the doubts? Journal of Proteomics & Bioinformatics 10:202\u2013206","journal-title":"Journal of Proteomics & Bioinformatics"},{"issue":"2\u20133","key":"1163_CR42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-2999(01)01570-9","volume":"435","author":"M Dukat","year":"2002","unstructured":"Dukat M, Damaj IM, Young R, Vann R, Collins AC, Marks MJ, Martin BR, Glennon RA (2002) Functional diversity among 5-substituted nicotine analogs; in vitro and in vivo investigations. Eur J Pharmacol 435(2\u20133):171\u2013180","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"1163_CR43","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3(12):1301\u20131306","journal-title":"Nat Neurosci"},{"issue":"1","key":"1163_CR44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1874143601206010012","volume":"6","author":"H Douna","year":"2012","unstructured":"Douna H, Bavelaar BM, Pellikaan H, Olivier B, Pieters T (2012) Neuroprotection in Parkinson\u2019s disease: A systematic review of the preclinical data. The Open Pharmacology Journal 6(1):12\u201326","journal-title":"The Open Pharmacology Journal"},{"issue":"3","key":"1163_CR45","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neuro.2008.02.001","volume":"29","author":"K Riveles","year":"2008","unstructured":"Riveles K, Huang LZ, Quik M (2008) Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells. Neurotoxicology 29(3):421\u2013427","journal-title":"Neurotoxicology"},{"issue":"1","key":"1163_CR46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0531-5131(03)01677-7","volume":"1260","author":"K Nakamura","year":"2004","unstructured":"Nakamura K, Kitamura Y, Tsuchiya D, Inden M, Taniguchi T (2004) In vitro neurodegeneration model: Dopaminergic toxin-induced apoptosis in human SH-SY5Y cells. Int Congr Ser 1260(1):287\u2013290","journal-title":"Int Congr Ser"},{"issue":"5","key":"1163_CR47","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/1087057112474468","volume":"18","author":"J Peng","year":"2013","unstructured":"Peng J, Liu Q, Rao MS, Zeng X (2013) Using human pluripotent stem cell-derived dopaminergic neurons to evaluate candidate Parkinson's disease therapeutic agents in MPP+ and rotenone models. J Biomol Screen 18(5):522\u2013533","journal-title":"J Biomol Screen"},{"issue":"5","key":"1163_CR48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tips.2007.03.001","volume":"28","author":"M Quik","year":"2007","unstructured":"Quik M, O'Neill M, Perez XA (2007) Nicotine neuroprotection against nigrostriatal damage: Importance of the animal model. Trends Pharmacol Sci 28(5):229\u2013235","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"1163_CR49","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jnr.21869","volume":"87","author":"H Takeuchi","year":"2009","unstructured":"Takeuchi H, Yanagida T, Inden M, Takata K, Kitamura Y, Yamakawa K, Sawada H, Izumi Y et al (2009) Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models. J Neurosci Res 87(2):576\u2013585","journal-title":"J Neurosci Res"},{"issue":"8","key":"1163_CR50","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.bcp.2007.06.015","volume":"74","author":"M Quik","year":"2007","unstructured":"Quik M, Bordia T, O'Leary K (2007) Nicotinic receptors as CNS targets for Parkinson's disease. Biochem Pharmacol 74(8):1224\u20131234","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1163_CR51","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1248\/bpb.32.332","volume":"32","author":"S Shimohama","year":"2009","unstructured":"Shimohama S (2009) Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models. Biol Pharm Bull 32(3):332\u2013336","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"1163_CR52","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1124\/mol.51.5.776","volume":"51","author":"X Peng","year":"1997","unstructured":"Peng X, Gerzanich V, Anand R, Wang F, Lindstrom J (1997) Chronic Nicotine Treatment Upregulates \u03b13 and \u03b17 Acetylcholine Receptor Subtypes Expressed by the Human Neuroblastoma Cell Line SH-SY5Y. Mol Pharmacol 51(1):776\u2013784","journal-title":"Mol Pharmacol"},{"issue":"1","key":"1163_CR53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2006.05.023","volume":"1101","author":"F Serres","year":"2006","unstructured":"Serres F, Carney SL (2006) Nicotine regulates SH-SY5Y neuroblastoma cell proliferation through the release of brain-derived neurotrophic factor. Brain Res 1101(1):36\u201342","journal-title":"Brain Res"},{"issue":"2","key":"1163_CR54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0925-4439(99)00029-0","volume":"1454","author":"W Linert","year":"1999","unstructured":"Linert W, Bridge MH, Huber M, Bjugstad KB, Grossman S, Arendash GW (1999) In vitro and in vivo studies investigating possible antioxidant actions of nicotine: Relevance to Parkinson's and Alzheimer's diseases. Biochim Biophys Acta 1454(2):143\u2013152","journal-title":"Biochim Biophys Acta"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1163-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1163-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1163-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T09:46:51Z","timestamp":1720345611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1163-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1163"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1163-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"27 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}